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ABSTRACT 
COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) EXPRESSION, 
DEGRADATION, AND SIGNALING IN LIPID-LADEN MACROPHAGES 
GREGORY THOMPSON 
2016 
 
 Atherosclerosis is a serious disease affecting a large portion of the world’s 
population. In atherosclerosis, macrophages become filled with lipid droplets and form 
fatty plaques in artery walls. The formation of these atherosclerotic plaques is dependent 
on the macrophage growth factor colony stimulating factor-1 (CSF-1); however, 
understanding the changes in CSF-1 signaling and related pathways in foam cells remain 
poorly investigated. Lipid-laden macrophages were formed through exposure of murine 
bone marrow derived macrophages to 100 µg/ml acetylated LDL for 24 h. Non-LDL 
treated macrophages were grown in parallel for each experiment and used for 
comparison. Immunofluorescent staining was used to visualize and quantify CSF-1R, 
pAkt, pERK, pCSF-1R, and Ki67. To synchronize the signaling process, macrophages 
were deprived of CSF-1 supplemented media before experiments. The lipid-laden 
macrophages had a decreased rate of CSF-1R expression. The degradation of CSF-1R 
was unchanged after the initial CSF-1 stimulation, but the level of phosphorylated 
receptor was lower in lipid-laden macrophages. The phosphorylation of Akt was 
unchanged during the first hour but increased in non-LDL exposed cells after 10 h. The 
phosphorylation of ERK spiked in non-LDL exposed cells at 7 min indicating a possible 
xii 
 
differential activation of pathways. Macrophage proliferation, as measured by Ki67 
staining, increased while the cells had lipid droplets then leveled as lipid droplets cleared 
from the cells. Lipid-laden macrophages also did not display differences in CSF-1 
stimulated macropinocytosis as observed with live-cell microscopy. Flow cytometry 
analysis revealed lipid laden macrophages had an increase in CD68, with decreased 
expression of CD11B and CD80. Differences in activation of signaling molecules 
highlight cellular functions affected by lipid droplets that can be targeted to prevent the 
proliferation of macrophages in plaques and promote plaque clearance. 
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Chapter 1 
 Literature Review 
 
 
1. Introduction 
The focus of this literature review is to present material pertinent to the 
understanding of atherosclerosis on a cellular level. I begin by presenting the major 
players involved in atherosclerosis; macrophages, serum lipoproteins, and the growth 
factor colony stimulating factor one (CSF-1). Understanding these different players 
provides insight into the widespread pathology of atherosclerosis and highlights potential 
directions for further research.  
2. Macrophages 
a. An introduction 
Macrophages have an interesting history and are a critical part of the immune 
system. Macrophages were discovered by Ilya Mechnikov who observed them attacking 
the thorns of a tangerine tree that had been introduced into a starfish larva. For his 
observation, Mechnikov received the 1908 Nobel prize (Ehrlich, 1967). The function of 
macrophages is highlighted within in their name: the prefix “macro” meaning large and 
the root “phage” meaning to eat, make the literal name of these cells “large eaters.” 
Macrophages live up to their name as their classic function is to phagocytose pathogens 
and cellular debris (Alberts, 2008). As phagocytic cells, macrophages are not dependent 
on any prior exposure to pathogens and are part of the innate immune system (Alberts, 
2008). From their initial discovery, macrophages have been found to have important and 
increasingly complex role in atherosclerosis, cancer, and infection. 
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  One source of macrophages are hematopoietic stem cells in the bone marrow 
(Geissmann et al., 2010). These macrophages are generated through the process of 
hematopoiesis. For the generation of macrophages, hematopoietic stem cells differentiate 
into myeloid progenitor cells, which further differentiate into monocytes that enter into 
circulation (Alberts, 2008). Once in circulation, monocytes can be differentiated into 
macrophages by the growth factor CSF-1, which is critical to the proliferation and 
differentiation of macrophages (Geissmann et al., 2010). The ability of CSF-1 to 
differentiate hematopoietic stem cells into macrophages was demonstrated in vitro in the 
1970’s (Metcalf, 1970; Stanley et al., 1978). CSF-1 is constitutively expressed within the 
serum from fibroblasts, macrophages, smooth muscle cells, and osteoclasts (Hamilton, 
2008) and is also upregulated along with other signaling molecules at sites of injury such 
as radiation (Xu et al., 2013). The generation of macrophages from hematopoietic stem 
cells provides a circulating pool of monocytes that can differentiate into macrophages. 
Tissue specific macrophages provide another source of macrophages. These 
macrophages differentiate from the yolk sac during embryogenesis and proliferate within 
specific tissues. Yolk sac macrophages make up the specialized populations such as the 
Kupffer cells of the liver, microglia of the brain, and Langerhans cells of the epidermis 
(Perdiguero et al., 2015). The ability of Langerhans cells to proliferate is demonstrated in 
a case study of a surgical patient with a hand transplant. The Langerhans cells of the 
donor hand continued to populate the hand and were not replaced by the hematopoietic 
stem cell-derived macrophages of the recipient (Kanitakis et al., 2004).  
The macrophage is the quintessential phagocytic cell of the body. These cells 
originally discovered in starfish, function in the innate immune system to phagocytose 
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debris and invading pathogens. Macrophages differentiate from bone marrow and 
multiply in tissues giving two sources of these critical cells. My focus will be on 
macrophages of hemopoietic origin and their role in supporting atherosclerosis. 
b. Macrophage differentiation and activation 
Just as circumstance can influence a person’s actions, the external stimulation that 
a macrophage receives can influence the cell’s functional role within the body. 
Macrophages are activated to particular transcription programs and phenotypes based on 
the conditions they encounter. Most frequently, macrophages are often characterized into 
M1 or M2 activation states based on the response to interferon gamma (IFN-γ) or 
lipopolysaccharide (LPS) (Mills et al., 000). In addition to M1 and M2 activation states, 
other categories for activation have been proposed and characterized (Gordon and Taylor, 
2005). Cellular surface markers, secreted cytokines, and cellular phenotypes such as the 
ability to phagocytose opsonized red blood cells are indicators used to categorize these 
cells. Increasing evidence suggests that the spectrum of macrophage activation is a 
continuum rather than a dichotomy (Mosser and Edwards, 2008). Further, these 
phenotypes are very plastic, and Mosser and Edwards have likened the assignment of 
categories to macrophages to “assigning color to a chameleon” (Mosser and Edwards, 
2008). Even with the growing theory of a continuum of differentiation, knowing the 
specific markers and secreted cytokines allows for predictions of cellular phenotype.  
M0 macrophages are a group of macrophages that are yet to be activated. In vitro 
M0 macrophages are routinely cultured. Hemopoietic stem cells are isolated from the 
bone marrow and cultured in the presence of the growth factor colony stimulating factor-
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1 (CSF-1). CSF-1 also stimulates the differentiation of monocytes into M0 macrophages 
(Chistiakov et al., 2015).  
M1 macrophages are considered the classically activated macrophage. M1 
stimulated macrophages promote inflammation and tissue damage along with inhibiting 
cell proliferation. The classic way to stimulate M1 polarization in macrophages is to 
expose the cells to endotoxin. Endotoxin, also known as lipopolysaccharide (LPS), is a 
component of gram-negative bacteria’s outer membrane. Other major stimulators that 
generate M1 macrophages are interferon gamma (IFN-γ) and tumor necrosis factor (TNF) 
(Martinez and Gordon, 2014). Once the M1 phenotype has been stimulated, these 
macrophages can be identified by looking at the markers expressed on their surface along 
with the cytokines that are produced. Surface markers of M1 macrophages include cluster 
of differentiation 68 (CD68) and toll-like receptor 4 (TLR-4) (Chinetti-Gbaguidi et al., 
2015). Cytokines expressed by these M1 macrophages include the pro-inflammatory 
cytokines tumor necrosis factor (TNF), interleukin-6 (IL-6), and interleukin-12 (IL-12), 
along with reactive oxygen and nitrogen species (Chinetti-Gbaguidi et al., 2015; Jones 
and Ricardo, 2013). M1 macrophages exhibit an inflammatory phenotype. 
M2 macrophages are considered anti-inflammatory and are on the opposite end of 
the activation spectrum from M1. These macrophages are involved in tissue repair and 
cell proliferation. M2 macrophages, known as alternatively activated macrophages, are 
stimulated to form with exposure to interleukin-4 (IL-4), involved in T-cell 
differentiation and produce anti-inflammatory cytokine interleukin-10 (IL-10) (Chinetti-
Gbaguidi et al., 2015). Further identification of M2 macrophages can be done with the 
surface markers CD163 and liver X receptor (LXR) (Chinetti-Gbaguidi et al., 2015). The 
5 
 
cytokine production profile of these cells varies but includes interleukin 10 (IL-10) and 
IL-4 (Chinetti-Gbaguidi et al., 2015).  It is also possible to divide M2 macrophages into 
wound healing macrophages and regulatory macrophages based on expression level of 
IL-10 (Mosser and Edwards, 2008).  
 Mox macrophages are stimulated by exposure to oxidized phospholipids 
(Chinetti-Gbaguidi et al., 2015), and express oxidant genes hem oxygenase 1 (Hmox1), 
sulfiredoxin 1 (Srxn1), Thioredoxin reductase (TXNRD), and glutathione reductase 
(GSR) (Kadl et al., 2010). The expression of these genes is not seen in the traditional M1 
or M2 macrophage and is dependent on Nuclear factor-like 2 (Nrf2) (Chistiakov et al., 
2015; Kadl et al., 2010). Mox macrophages express TLR-2 and Nrf2 and produce IL-1β 
and cyclooxygenase-2 (COX-2) (Chinetti-Gbaguidi et al., 2015). These macrophages are 
pro-atherogenic and make up 30% of macrophages in atherosclerotic lesions, in LDL 
receptor knockout mouse model (Chistiakov et al., 2015; Kadl et al., 2010). 
M4 macrophage are another subset of macrophages found in atherosclerotic 
plaques of humans (Chistiakov et al., 2015). M4 macrophages are induced by ligand 4 
(CXCL4), express CD206, matrix metalloproteinase-7 (MMP7) and calcium binding 
protein A8 (S100A8) while producing the cytokines IL-6, TNF-α, and MMP12 
(Chistiakov et al., 2015).  
Hemoglobin stimulated macrophages (M(hb)), hemorrhage associate 
macrophages (HA-mac) and a similar group of macrophages that respond to heme and 
hemoglobin (Mhem) macrophages are found in atherosclerotic plaques. M(hb), HA-mac, 
and Mhem macrophages are atheroprotective (Chistiakov et al., 2015). These 
macrophages express ATP-binding cassette transporter (ABCA1) and ATP-binding 
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cassette transporter sub-family G (ABCG1) transporters that allow them to efflux 
cholesterol (Chistiakov et al., 2015).  
3. Plasma lipoproteins  
Lipoproteins function to move hydrophobic cholesterol through the hydrophilic 
environment of the body. These molecules are made up of a monolayer of phospholipids 
with a hydrophobic core (Cox, 1990). Different types of apolipoproteins move 
cholesterol to and from different cells in the body. For example, low density lipoprotein 
(LDL) is responsible for bringing cholesterol to cells in the body from the liver. Because 
high serum concentrations of LDL have been associated with poor health outcomes, LDL 
has been coined “bad cholesterol”.  Alternatively, high density lipoprotein (HDL) is 
commonly referred to as “good cholesterol” as it carries cholesterol away from the cells 
of the body and high serum levels have been associated with good health outcomes 
(American Heart Association, 2016). 
a. Structure  
Lipoproteins are defined in part by their density and can be isolated from serum 
by ultracentrifugation. LDL is isolated in the density range of 1.019-1.063g/ml. The LDL 
particle is made up of a phospholipid monolayer with embedded proteins surrounding a 
core of cholesterol and triglycerides. The LDL particle is 50% cholesterol, 25% protein, 
20% phospholipid, and 5% triglyceride. The mass of LDL varies from 2.4-3.9 MDa. 
Interestingly, the one molecule of apo-B100 makes up over 95% of the protein mass and 
is the signature protein of LDL (Rajmanet al., 1999). Lipoproteins also fall into other 
categories such as HDL, very low density lipoprotein (VLDL), and intermediate density 
lipoprotein (IDL). Besides having different densities, these lipoproteins have different 
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protein profiles. The embedded proteins allow the different lipoproteins to deliver their 
cargo to its target cell type. 
b. Modifications 
Chemical modifications to LDL occur and are relevant to plaque formation and 
pathogenesis. Oxidized LDL is the most important modification for the formation of 
atherosclerotic plaques, as oxidized LDL is readily taken up by macrophages (Steinberg 
and Witztum, 2010). Oxidation of LDL occurs naturally in the body via reactive oxygen 
species present due to metabolic process (Arai, 2014). Inflammation and infection also 
induce the formation of oxidized LDL in vivo (Memon et al., 2000). LDL can be 
acetylated through the exposure of LDL to saturated sodium acetate and acetate 
anhydride in vitro (Reza, 2010). Acetylated LDL is taken up by macrophage scavenger 
receptors; however, it has not been proven to exist in vivo (Steinberg and Witztum, 
2010). Despite having different modifications, acetylated LDL and oxidized LDL are 
both taken up by macrophage scavenger receptors and delivered to the same lysosomes 
(Yancey et al.,2002). There are differences in the transport of cholesterol out of the cell 
and the oxidized components of oxidized LDL can impair degradation and stimulate 
inflammatory phenotype (Wang et al., 2007).  
c. Epidemiology 
High levels of cholesterol in blood are associated with higher risk for 
atherosclerosis. The National Cholesterol Education Program (NCEP) and the National 
Lipid Association have set the desirable total cholesterol level to be <200mg/dl (2,000 
µg/ml). Approximately 15% of US adults over 20 have serum cholesterol levels over 
240mg/dl (2,400 µg/ml) or greater and 69% of US adults have low density lipoprotein 
cholesterol (LDL-C) above 100mg/dl (1,000 µg/ml) (Jellinger et al., 2012). The high 
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levels of hypercholesterolemia and its significance in cardiovascular disease point to a 
need to understand disruptions in macrophages cell biology due to LDL uptake and lipid 
droplet formation. 
4. Lipid droplets 
Lipid droplets are organelles found within nearly all cells (Walther et al., 2012). 
The basic structure of lipid droplets is similar to that of lipoproteins in circulation, with a 
phospholipid monolayer surrounding a hydrophobic core. However, lipid droplets can be 
much larger - ranging in size from a few nanometers to 100 µm in white adipocytes (Guo 
et al., 2009). The formation of lipid droplets occurs at the endoplasmic reticulum (ER). 
Lipids are trafficked from the lysosome to the ER and build up between leaflets of the 
phospholipid bilayer until the monolayered droplets buds off. The exact process of lipid 
droplet formation from the ER is still being studied with the ER domain and budding, the 
bicelle, and vesicular budding models proposed (Guo et al., 2009). The structure and 
formation of lipid droplets in cells of the immune system still presents many exciting 
opportunities for discovery. 
 Lipid droplets are a dynamic organelle with changing morphology and internal 
membranes (Walther and Farese, 2009). Changes in morphology takes place in situations 
like infection and phagocytosis. The electron density of lipid droplets in activated 
macrophages changes due to the synthesis of eicosanoids (prostaglandins, leukotrienes, 
and lipoxins) within the lipid droplets (Bozza et al., 2011). Lipid droplets contain internal 
membranes that form a network of tubules resembling the ER (Melo et al., 2013). In 
macrophages lipid droplets are considered structural markers of activation (Bozza et al., 
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2007). Research into lipid droplets has opened many more questions than have been 
answered unveiling an exciting and previously overlook organelle. 
5. Colony stimulating factor one (CSF-1) and signaling  
a. Structure and signaling 
CSF-1R is a tyrosine protein kinase that promotes the growth and proliferation of 
macrophages. The receptor is activated when a homodimer is formed following binding 
of dimerized ligand and the receptors transphosphorylate each other. After 
phosphorylation, CSF-1R binds Grb2 and activates PI3K that in turn propagate and 
amplify the signal within the cell (Husson et al., 1997; Sampaio et al., 2011). This 
signaling supports cell growth, differentiation, survival, and stimulates macropinocytosis 
or chemotaxis.  
  
Figure 2. CSF-1R activated pathways within the cell, once the dimerized CSF-1 
ligand binds to the receptor, the CSF-1R receptor also dimerizes. The receptors 
transphosphorylate each other binding Grb2 and activating PI3K. This in turn leads to 
differentiation and growth, survival, and macropinocytosis or chemotaxis. The receptor 
dimer is then ubiquitinated and degraded.  
 
b. CSF1R Internalization and degradation 
  After the CSF-1 ligand binds to CSF-1R, the activated dimer is internalized by 
small vesicle endocytosis (Lou et al., 2014). Based on experimental addition of inhibitors 
10 
 
at time points after CSF-1 addition, CSF-1R continues signaling in early endosomes after 
being trafficked from the cell membrane (Huynh et al., 2012). These early endosomes are 
trafficked to macropinosomes (Lou et al., 2014). The timeline for this process is short 
with CSF-1R going from the cell surface to degradation in minutes. A disruption in the 
rate of degradation may lead to altered biology of the cell because of prolonged CSF-1R 
signaling.  
 
Figure 2. The degradation of the CSF-1R occurs quickly after ligand binding. The 
receptor is internalized into early endosomes that continue signaling. Early endosomes 
are trafficked to macropinosomes before degradation. 
 
c. Akt signaling 
 Akt, also known as protein kinase B (PKB), is a well-studied intermediate 
signaling molecule within cells critical for growth, survival, and proliferation (Hart and 
Vogt, 2011). Akt is activated through phosphorylation at different sights with S473 being 
important for a tenfold increase in the catalytic activity (Alessi et al., 1996). Once 
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phosphorylated, Akt passes the signal downstream to target of rapamycin complex 1 
(TORC1), the forkhead box (FOX) transcription factors that are tumor suppressers, and 
murine double minute (MDM2) involved in metabolism (Hart and Vogt, 2011). The 
localization of Akt and level of phosphorylation observed in cells can be used to predict 
the cells’ biology. Cells with nuclear localization of pAkt have extended lifespans 
(Martellia, 2012). Bone marrow derived macrophages exposed to oxidized LDL have 
decreased survival and proliferation that can be prevented by transfecting cells with 
constitutively active Akt (Chu et al., 2011). 
d. ERK signaling 
 Extracellular-signal-regulated kinases (ERK) are classical MAP kinases that are 
phosphorylated when CSF-1R is activated and transmit the signal through the cytoplasm. 
The phosphorylation of ERK has been demonstrated to be important for the expression of 
the D2 cyclin genes (Dey et al., 2000). Cyclins are used by cells to regulate proliferation 
supporting the role of CSF-1R and pERK in cell proliferation. 
6. Disease and lipid laden macrophages 
Though macrophages are an important part of the immune system, they also can 
be involved in pathology. Lipid laden macrophages can be found with several diseases 
including infections and metabolic disorders. Infections agents that cause lipid droplet 
formation in macrophages include Candida albicans, Chlamydia pneumonia, Leishmania 
amazonensis, Mycobacterium, and Trypanosoma cruzi (Dias et al., 2014). Lipid droplet 
formation in macrophages is associated with diabetes and atherosclerosis, the hormones 
leptin and resistin, and inflammatory stimuli (Dias et al., 2014). Here, I will focus on 
lipid-laden macrophages and atherosclerosis. 
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a. LDL uptake by macrophages 
LDL is taken up by macrophages through three mechanisms: LDLR mediated 
uptake, scavenger receptors, and macropinocytosis (Arai et al., 1989; Herijgers et al., 
2000; Kruth et al., 2005).  The LDLR mediated uptake can make a significant 
contribution to plaque formation in vivo (Herijgers et al., 2000). Macrophages express 
the LDL receptor that recognizes apoprotein B-100 found on LDL (Zaiou et al., 2000). 
Modified LDL such as oxidized and acetylated bind scavenger receptors CD36, 
scavenger receptor A, CD68, and LOX-1 (Boullier et al., 2001). Scavenger receptors are 
used by macrophages to remove foreign and damaged cellular material from the body 
(Peiser and Gordon, 2001). Besides receptor-mediated pathways of uptake, LDL can be 
taken up by macropinocytosis (Kruth, 2011; Kruth et al., 2005). 
b. Epidemiology of atherosclerosis 
Atherosclerosis is serious and widespread disease that affects a large percentage 
of people. Atherosclerosis is the underlying pathology for many serious diseases 
including coronary artery disease, carotid artery disease, peripheral artery disease, and 
chronic kidney disease (NIH, 2015). Coronary artery disease alone was responsible for 1 
of every 6 deaths in 2007, in the United States (Jellinger et al., 2012). In 2012 the World 
Health Organization listed coronary artery disease as the top killer of people in the world 
with 7.4 million deaths (WHO, 2014). The grave outcome of this pathology along with its 
widespread nature presents great benefit to understanding the underlying causes and cell 
biology of pathogenesis. 
The hallmark of atherosclerosis is the formation of plaques in the intima of the 
arteries. In coronary artery disease, the plaques form in the coronary arteries that supply 
oxygen to the heart. Carotid artery disease involves the buildup of plaques in the carotid 
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arteries in the neck, in peripheral artery disease the plaques occur in the arteries of arms 
and legs, and in chronic kidney disease, the plaques occur in the renal arteries (NIH, 
2015). These plaques restrict blood flow and can destabilize and rupture causing 
blockage and clotting in the arteries. With atherosclerotic plaques being central to the 
pathology of atherosclerosis, understanding their formation is of utmost importance.  
c. Formation of atherosclerotic plaques 
Plaque formation involves both cholesterol and the cells of the immune system. 
The plaque begins as a fatty streak that is the precursor to the atherosclerotic lesion. In 
some cases, and especially in younger people these streaks may simply disappear (Stary 
et al., 1994). The lesion itself is dominated by immune cells along with the buildup of 
lipids, calcium, and cellular materials (Stary et al., 1994). The buildup of these materials 
within the walls of the artery causes constriction of the vessels and limits blood flow 
(Stary et al., 1994). Macrophages and T-cells make up a majority of the immune cells in 
the fatty streak (Stary et al., 1994). LDL is a major component of the atherosclerotic 
plaque (Saxena and Goldberg, 1994).  The center of the plaques become filled with both 
macrophages and extracellular lipid droplets and a cap of smooth muscle cells can form 
(Hansson, 2005). Under the cap, a necrotic core may develop leading to instability and 
the potential for destabilization and rupture. If the plaque does rupture, clotting in the 
artery leads to blockage of the vessels that can cause injury or death of the tissue (Van 
Der Wal and Becker, 1999). 
d. CSF-1 in atherosclerosis 
The importance of CSF-1R in atherosclerosis is highlighted in a knockout mouse 
experiment (Smith et al., 1995). Mice with an Apo-E and CSF-1 double knock out had 
significantly smaller plaques and with higher mean blood cholesterol levels than the just 
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Apo-E controls (Smith et al., 1995). Apo-E knockout mice cannot produce apolipoprotein 
E that is needed for all lipoproteins except LDL, it is synthesized by the liver, brain, 
monocytes, and macrophages (Meir and Leitersdorf, 2004).  The deficiency of Apo-E 
causes high levels of blood cholesterol and atherosclerosis. The decrease in 
atherosclerosis in these double knockout mice could be due to decreased macrophage 
populations or changes in macrophage signaling in the absence of the CSF-1 ligand.  
Oxidized LDL is able to promote the growth and proliferation of macrophages in 
the absence of growth factors CSF-1 and GM-CSF and increase the proliferative response 
to those growth factors (Hamilton et al., 1999). Exposure to low concentrations of 
oxidized LDL (50 µg/mL) led to growth and survival of macrophages in the absence of 
CSF-1 and GM-CSF while concentrations over 100 µg/ml lead to cell death (Hamilton et 
al., 1999). 
e. Treatment and prevention 
Treatments of atherosclerosis have primarily focused on lowering the amount of 
cholesterol in the blood. This can be done with changes in a person’s diet or through the 
use of medications such as simvastatin that targets a reductase of LDL and pravastatin 
that also inhibits cholesterol synthesis (Pedersen et al., 1994; Shepherd et al., 1995). 
Vaccines for atherosclerosis are under development, and the first vaccines were against 
the ApoB-100 protein and heat shock proteins, as heat shock proteins induce 
atherosclerosis. These vaccines have shown to be effective in animals and are now 
approaching clinical testing (Nilsson et al., 2013). Though not currently in use, 
suppression of macrophage recruitment plaques in knock out mice has shown to b e a 
promising target for future therapies (Potteaux et al., 2011) 
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 7. Conclusion 
Atherosclerosis is a complex disorder that can benefit from a cellular level 
investigation of macrophage biology. Even though CSF-1 is significant to the formation 
of atherosclerosis and macrophages, the effect of lipid droplet load on receptor 
expression, signaling, and related pathways remains poorly characterized. 
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Chapter 2  
Lipid burden alters CSF-1 receptor signaling and traffic 
 
 
Introduction 
 Atherosclerosis is a serious and widespread disease with a subset of 
atherosclerosis, coronary artery disease, being responsible for 1 in 6 deaths in the United 
States (Jellinger et al., 2012). Coronary artery disease alone was considered by the world 
health organization to be the top killer of people in the world (WHO, 2014). The 
hallmark of atherosclerosis is the formation of a fatty plaque in the arteries made up of 
macrophages filled with lipid droplets (Stary et al., 1994). The macrophages fill with 
lipid droplets and seemingly become trapped in the plaques, where they produce pro-
inflammatory cytokines such as tumor necrosis factor alpha (TNFα), interleukin-6 (IL-6), 
and interleukin-1β (IL-1β) (Autieri, 2012). This inflammation can lead to plaque rupture 
that initiates clotting cascades within the arteries (Van Der Wal and Becker, 1999).  
 The growth factor, colony stimulating factor one (CSF-1), has both a positive and 
negative relationship with atherosclerosis. The phosphorylation of CSF-1R stimulates 
several pathways within macrophages that lead to chemotaxis, macropinocytosis, 
survival, and proliferation (Pixley and Stanley, 2004). In a mouse model for 
atherosclerosis the knockout of CSF-1R caused a significant decrease in atherosclerotic 
plaque area in the aortic root (Smith et al., 1995). Interestingly, the administration of 
CSF-1 to hyperlipidemic rabbits suppressed atherosclerotic lesions, indicating that there 
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is not a simple linear relationship between CSF-1 and atherosclerosis (Chitu and Stanley, 
2006). 
 Macrophages respond to CSF-1 by activating and propagating signaling cascades 
within the cell. CSF-1 binds to the colony stimulating factor one receptor (CSF-1R), 
CSF-1R then forms a dimer and auto-phosphorylates, before phosphorylating other 
signaling molecules leading to Akt and ERK phosphorylation (Pixley and Stanley, 2004). 
CSF-1R is subsequently internalized into early endosomes where it presumably continues 
signaling (Huynh et al., 2012). The early endosomes then fuse with the macropinosomes 
before degradation (Lou et al.,2014). The activation of different signaling pathways 
dictates the macrophages response to CSF-1. 
  Cell culture allows for a pointed study of CSF-1R in lipid-laden macrophages, 
like those found in atherosclerotic lesions. Modified LDL is taken up by scavenger 
receptors and non-modified LDL is taken up by the LDL receptor or macropinocytosis to 
form lipid-laden macrophages (Kruth, 2011; Kruth et al., 2005). Cultured lipid-laden 
macrophages can be used to investigate cellular response to CSF-1 and changes in 
receptor expression. Removal of supplemental CSF-1 from culture media causes an 
upregulation of the CSF-1R on the cell surface. Saturating this receptor by adding back 
CSF-1 to the macrophages causes a synchronized signaling and internalization of the 
receptor. By investigating how lipid-laden macrophages differ from normal macrophages 
in their cellular response to CSF-1, we can better understand the pathogenesis of 
atherosclerosis. 
24 
 
Materials and Methods  
Media types and preparation 
Bone marrow media (BMM) was used to differentiate and grow bone marrow 
derived macrophages. BMM consisted of 20% premium heat inactivated fetal bovine 
serum (FBS) (Atlanta Biologicals, Flowery Branch, GA), 30% L-cell conditioned media, 
with Penicillin and Streptomycin (Pen Strep) (30-002-Cl, Corning, Manassas, VA), and 
2-mercaptoethanol (ThermoFisher Scientific, Waltham, MA) in Dulbecco’s modification 
of Eagles Media containing 4.5 g/L glucose, L-glutamine and sodium pyruvate (DMEM) 
(Corning, Manassas, VA). Before use these components are filtered with a 0.46 μm 
vacuum filter (EMD Millipore, Darmstadt, Germany). 
L-cell conditioned media was grown in the lab. L-cells were seeded into 75 cm2 
tissue culture treated flasks (Corning, Manassas, VA) with 10% FBS and Pen Strep in 
DMEM. L-cell growth was observed daily. The L-cells became confluent approximately 
4 days’ post plating.  They were allowed to grow for 3 additional days before harvesting 
supernatant. The supernatant was removed from the T75 flasks and frozen in 50 mL tubes 
until it was needed to make BMM. After harvesting media, flasks were washed with 5 
mL of sterile PBS (GE Healthcare Life Sciences, Pittsburgh, PA) before the addition of 5 
mL of 0.05% trypsin (Corning, Manassas, VA). Trypsin was added the plates were 
incubated at 37°C until the L-cells were easily be detached by pipetting. The L-cells were 
then centrifuged at 300 g (Allegra X-14R centrifuge, SX4750A rotor, Beckman Coulter, 
Brea, CA) for 5 min and suspended in 10% FBS in DMEM. The cell suspension was then 
used to seed the next round of flasks. The L-cells express the growth factor CSF-1 that is 
needed to support the differentiation, growth, and proliferation of macrophages.  
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Live cell imaging buffer (LCIB) was used for imaging and time course 
experiments outside of the CO2 buffered incubator. LCIB consists of DPBS 0.9 mM Ca 
0.49 mM Mg (GE Healthcare Life Sciences, Pittsburgh, PA), with 0.45% glucose 
(Corning, Manassas, VA), and 10 mM HEPES (GE Healthcare Life Sciences, Pittsburgh, 
PA). 
Bone Marrow Macrophage isolation 
 Adult black 6 (C57BLJ) mice were acquired (Jackson Laboratories, Bar Harbor, 
ME) and allowed to equilibrate to their new environment after transport before euthanasia 
with CO2 (Swanson, 1989). Femurs were harvested from the mice with care being taken 
to maintain the integrity of the bone. After harvesting the ends of the femurs were cut off 
and the bone marrow flushed from the bones with the use of DPBS -Ca -Mg (GE 
Healthcare Life Sciences, Pittsburgh, PA) delivered through a 0.5 inch, 26-gauge needle 
and 5 ml sterile Luer Lock syringe. The isolated bone marrow was centrifuged at 500 g 
for 5 minutes. The pellet of cell was then suspended in BMM. Cells where plated at a 
density of 10 million cells per non-tissue culture treated, sterile, 10 cm petri dish with 10 
ml of BMM. Plates were placed in an incubator at 5% CO2 and 37°C. Plates were 
allowed to grow for 2 days before the addition of an additional 10 mL of fresh pre-
warmed BMM to the plates. After an additional two days the macrophages stick to the 
bottom of the plate and the media can be removed and replaced with 10 ml of fresh 
BMM. To maintain an optimal level of growth factors and nutrients in the media the 
media was removed and replaced with 10 ml of BMM every two days. The nomenclature 
used for these cells starts with D0 macrophages on the day of isolation and plating. Cells 
on the following day are referred to as day 1 (D1) macrophages and that pattern continues 
throughout the lifespan of the cells with the day 4 (D4) macrophages adhering to the 
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plate. To maintain macrophages in growth phase, cells were observed and re-plated when 
the plates approached confluency. Macrophages from these isolations were either re-
plated for experiments or frozen down for later use. 
Detaching cells in culture 
 Detaching macrophages from the petri dishes allowed for re-plating for 
experiments, maintenance of cultured cells density, and freezing of cells for later use. 
Cells were detached from plates with cold, sterile, DPBS -Ca -Mg. Bone marrow media 
is first removed and the plates washed with 5ml of 4°C DPBS -Ca -Mg to remove the 
remaining media. Then 10ml of 4°C DPBS -Ca -mg was added to the plates and the 
plates were placed in the refrigerator for 20 minutes. After sitting in the refrigerator (4°C) 
macrophages rounded up and detached from the plate. Macrophages were further 
detached by pipetting. Cells were spun at 300 g for 5 min in 15 ml falcon tubes and re-
suspended in selected media.  
Freezing Cells  
 Freezing down of cells was done on the desired day after bone marrow isolation 
for primary bone marrow macrophages. Cells were detached from culture dishes and 
suspended in BMM. Concentration was determined with the use of a hemocytometer and 
trypan blue (GE Healthcare Life Sciences, Pittsburgh, PA). A 1:1 ratio of cells containing 
media and trypan blue allow for differential identification of live and dead cells. After 
counting cells were diluted with additional BMM to a final concentration of 1.1 million 
cells per ml before the addition of 10% DMSO (Corning, Manassas, VA) to the media. 
Immediately after addition of DMSO, 1 ml of cells was aliquoted into 1.5ml cryo-vials 
and put into CoolCell cell freezing containers for at least 4 h in the -80° freezer. After this 
time the cells are transferred to a liquid nitrogen tank for long term storage.   
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Plating cells 
 Macrophages grown in culture and from liquid nitrogen were plated in to petri 
dishes, 24 well plates, 6 well plates, and 96 well plates. Cells from liquid nitrogen were 
thawed quickly in a 37°C water bath and suspended in 10 ml of BMM. After suspension 
cells were spun at 300 g for 5 min and suspended in BMM before being counted with 
trypan blue and a hemocytometer. Cells were then plated at a density of 10,000-20,000 
cell per well in 100μl for a 96well plate, 50,000 cells per well in 0.5 ml media for 24 well 
plate, 300,000 cells per well in 3 ml media for a 6 well plate, and 1,000,0000 cells per 10 
ml of media in a 10 cm dish. 
 Macrophages that were plated into 24-well and 6-well plates were put directly 
onto glass coverslips. The coverslips used were 12 mm for the 24 well plates and 25 mm 
for the 6 well plates, #1.5 circular glass (ThermoFisher Scientific, Waltham, MA). Before 
putting coverslips into the empty plate, they were dipped in 95% ethanol and flamed, to 
sterilize them. Macrophages were plated onto glass to improve image quality for 
immunofluorescent and live cell experiments. 
LDL Exposure/loading 
 Macrophages were grown to the desired day post isolation. Before the addition of 
LDL to the culture media macrophages were plated onto the glass or optical bottom 96-
well plates, unless the macrophages were to be used in a flow cytometry experiment. 
Oxidized, acetylated, and native (non-modified LDL) were used (Alfa Aesar, Ward Hill, 
MA). Concentrations of LDL were varied in experiments. A majority of the experimental 
results presented here were generated with 100 μg/mL acetylated LDL. LDL was added 
in either BMM or DMEM+10%FBS and loaded overnight. Figures for experiments 
contain notes of LDL type and concentration used.  
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CSF-1 activation time course  
To better visualize trafficking of CSF-1R and phosphorylation of pAkt, pERK, 
and pCSF-1R, cells were deprived of CSF-1 to upregulate expression of the receptor. 
This is done so that upregulated expression will allow for the best visualization of the 
receptor throughout the attenuation and signaling process. CSF-1R expression after CSF-
1 ligand removal was also observed. BMM was removed from cells 24 h prior to the 
experiments and DMEM high glucose plus 10% FBS was added so that macrophages 
would upregulate CSF-1R expression. Recombinant murine CSF-1 (BioLegend, San 
Diego, CA) was then added to cells at a concentration of 0.2μg/mL in LCIB and cells 
were fixed at time points past this initial stimulation with 4% paraformaldehyde (PFA) 
(ThermoFisher Scientific, Waltham, MA). 
Immunofluorescence cell staining 
 Immunofluorescent (IF) staining was used to visualize and quantify CSF-1R, 
pCSF-1R, pERK, pAkt, and Ki67. IF staining was done on both glass coverslips and in 
96 plates. Cell were fixed with 4% PFA in PBS for 10 minutes. After fixation cells were 
permeabilized to allow antibodies access to the inside of the cells, some coverslips were 
not permeabilized in order to only see surface expression. Cells were permeabilized for 
30 minutes with 0.1% Triton-X 100 (ThermoFisher Scientific, Waltham, MA) in PBS. 
Blocking for non-specific binding with 2.5% BSA in PBS was done for at least an hour. 
Primary antibodies were added to the cells in 2.5% BSA (ThermoFisher Scientific, 
Waltham, MA) for at least one hour at room temperature. Antibodies for phosphorylated 
proteins were kept on cells overnight at 4°C. After staining with primary antibody the 
species specific secondary antibody was added a 1:500 dilutions for one hour to two 
hours. 
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Table 1. Primary antibodies used for immunofluorescent staining coverslips 
Primary Antibody to Clone Type Supplier Species 
Mouse CS115 (CSF1R) AFS98 Monoclonal eBioscience Rat 
Human Ki67 Antibody SP6 Monoclonal abcam Rabbit 
p-CSF1R Receptor 
(Y723) 49C10 Monoclonal Cell Signaling Rabbit 
(pERK) p-p44/42 
MAPK (T202/y204) D13.14.4E Monoclonal Cell Signaling Rabbit 
pAkt S473 D9E Monoclonal Cell Signaling Rabbit 
 
 Cell and nuclear masks were stained to facilitate automated image analysis. 
Nucblue (ThermoFisher Scientific, Waltham, MA) was used for nuclear staining, which 
was added to cells at the recommended 2 drops per mL, for 5 minutes. Dye 647-I 
phalloidin (Abnova, Jhongli, Taiwan) was used to mask cells. The phalloidin was added 
for 20 minutes at a 1:100 dilution in BSA.  
 Several lipid stains were trialed with Oil Red O being used for a majority of 
experiments. A stock solution of Oil Red O (Sigma-Aldrich, St. Louis, MO) was 
prepared by dissolving 0.4% Oil Red O in 100% isopropanol (ThermoFisher Scientific, 
Waltham, MA). The same day of use, Oil Red O stock was diluted to 60% isopropanol 
with deionized water. This 60% working solution was filtered to remove undissolved 
particles. The Oil Red O stain was added to the cells for 30 sec before removal and 
copious washes with PBS. Care was taken to not allow the Oil Red O to dry out during 
the washing steps as this leads to high background fluorescence.  
 After staining, cells fixed for microscopy were mounted or put in PBS with 
sodium azide (Santa Cruz Biotechnology, Dallas, TX). Stained glass coverslips were 
picked up with tweezers and the water wicked away with contact on the edge with a 
paper towel. After the removal of water, coverslips were inverted onto a droplet of 
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Flouromount-G (Southern Biotech, Birmingham, AL) on a glass slide. Flouromount-G 
was allowed to dry for at least half an hour before the edges of the coverslip were tacked 
down with clear nail polish. The nail polish is to prevent the coverslip from coming off of 
the slide or moving. Cells in 96 well plates had the media replaced with PBS plus sodium 
azide to prevent any growth of bacteria or fungus in the plate before imaging.  
 To facilitate washing of the coverslips between the different staining steps a 
vacuum pump was used to remove liquid from coverslips. The pump was attached to a 
1000ml Erlenmeyer flask via the flasks side arm. A shortened 10 mL serological pipette 
was inserted into the central in the rubber stopper, a good seal was achieved by wrapping 
the pipette with parafilm, and glass wool was removed. The pipette tip was connected to 
the serological pipette and a pipette tip via latex tubing. A secondary pipette tip was used 
to remove the stain and wash solutions from the coverslips.  
Imaging 
 Fixed coverslips were imaged with the use of fluorescent microscopes. An EVOS 
FL imaging system was use with GFP (Alexa 488 secondary antibody), TxRed (Oil Red 
O or LipidTOX), DAPI, and Cy5 (647 phalloidin) filter cubes (ThermoFisher Scientific, 
Waltham, MA). An Andromeda spinning disk confocal microscope was used for the 
acquisition of live cell images. The 561nm laser with Zet 442/514/561x excitation wheel 
and 605/64 emission wheel were used for “red”. The 445 laser with Zet 442/514/561x 
excitation wheel and 537/26 emission wheel were used for “green”. 
Dextran uptake in live cells 
Bone marrow derived macrophages were grown on 25 mm coverslips in 6-well 
plates. These cells were plated at a density of 3 x 105 cells per well. Coverslips were 
taken and put into imaging chambers with live cell imaging buffer (LCIB). Large 
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fluorescent dextrans were used to image macropinocytosis. Texas Red tagged to 70 kDa 
dextran was used as it is size excluded from most forms of internalization such as 
endocytosis and can be taken up with macropinocytosis. Lucifer yellow was used in 
addition to recombinant CSF-1 to visualize stimulated macropinocytosis. The Lucifer 
yellow in LCIB with CSF-1 was added to the cells for 2 minutes to load 
macropinosomes. The cells were then washed to remove non-internalized Lucifer yellow. 
Nile red (ThermoFisher Scientific, Waltham, MA) was used to stain lipid droplets 
in live cells. A 1 mM solution of Nile red in DMSO was diluted to a 1 µM working 
solution in LCIB. This 1 µM solution was used to stain cells for 5 minutes before cells 
washing with LCIB and imaging.  
Flow cytometry 
 Macrophages were grown in culture to the desired day from stock D4 
macrophages in liquid nitrogen. These cells were grown in 10 cm petri dishes, with one 
dish of control cells and another dish of cells treated with 100 µg/mL acetylated LDL 
overnight. Cells were detached from plates with cold DPBS without calcium or 
magnesium, then fixed with 4% PFA for 10 min. Staining was done directly with 
conjugated antibodies and Nile red to quantify lipid content (Greenspan et al, 1985). 
Table 2. Antibodies used in flow cytometry 
Primary antibody Clone Fluorophore Manufacturer 
CD68 FA-11 Alexa Fluor 488 BioLegend 
IA/I-E (MHCII) M5/114.15.2 Alexa Fluor 647 BioLegend 
CD80 16-10A1 PE BioLegend 
CD11B M1/70 Alexa Fluor 488 BioLegend 
CD14 Sa14-2 APC BioLegend 
CD115 Afs98 PE BioLegend 
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Image analysis 
 Image analysis and quantification was done with the use of open source software 
packages ImageJ and CellProfiler (Carpenter et al., 2006; Rasband, 1997-2016). ImageJ 
was used to visualize raw images and process the images into montages (Rasband, 1997-
2016). Quantification of image data was done through the use of the program CellProfiler 
(Carpenter et al., 2006). Images were quantified using cell masks constructed from F-
actin staining, assisting this process was the requirement that each cell mask contain one 
nuclear mask. The image analysis pipelines along with the images used have been 
retained for reference and adjustment of analysis parameters. 
Statistics 
 The open source statistical package R version 3.3.0, 64 bit, for Windows was used 
for the analysis of the output from CellProfiler (R Team, 2008). Graphical representation 
of data utilized the R package “ggplot2” (Wickham, 2009). 
Results 
 Experiments began by establishing lipid droplet loading and staining then moved 
to looking at signaling and outcomes. Lipid droplet loading looked at media type, and 
LDL modification. Staining looked into the use of different stains and protocols. 
Signaling investigated the expression of CSF-1R and then at the phosphorylation of 
signaling intermediates post CSF-1 stimulation. Ki67 was used to look at cell 
proliferation and live cell imaging with fluorescence to look at macropinocytosis.   
Macrophages exposure to acetylated LDL produced lipid droplets that readily stained 
with Oil Red O 
 Dose response experiments determined optimal conditions for loading primary 
bone marrow derived macrophages with lipid droplets and procedures for staining them. 
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The first experiment assessed formation of lipid droplets in macrophages exposed to 50 
µg/ml, 100 µg/ml, and 150 µg/ml acetylated LDL for 48 h (Figure 1). Some control cells 
(<10%) showed small lipid droplets. Subsequent experiments demonstrated this 
population of lipid droplet containing control cells persisted and that 24 h of exposure to 
100 µg/ml acetylated LDL loaded the macrophages with lipid droplets as effectively as 
the 48 h exposures (Figure 1).  
 A concentration of 100 µg/ml acetylated LDL was used for subsequent 
experiments, because it showed more consistent loading than non-modified LDL. Even at 
500 µg/ml and 48 h exposure times, the non-modified LDL loaded a small percentage of 
cultured macrophages (Figure 2). The loading of macrophages with acetylated LDL 
appeared to be independent of the whether LDL was delivered in BMM or 
DMEM+10%FBS (Figure 2). This independence from media type allowed for the 
combination of CSF-1 starvation and lipid loading in some experiments. Macrophages 
were also exposed to oxidized LDL, which showed levels of lipid droplet formation in 
between levels seen in cells exposed to acetylated and non-modified forms of LDL (data 
not shown).  
 Different lipid stains were tested and Oil Red O was found to be the most 
consistent, fastest, and cheapest method to visualize lipid droplets. The fixed cell stain, 
LipidTox, was much slower and dimmer than Oil Red O. The live cells-stain 
monodansylpentane (MDH) worked well to visualize lipid droplets in the DAPI channel 
and was also effective at high concentrations at staining fixed cells. Nile Red initially 
worked well as a live cell lipid droplet stain however its results have been inconsistent, 
possibly due to its storage (data not shown). 
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CSF-1R expressed more slowly, degradation at the same rate, and was less 
phosphorylated in LDL-exposed cells 
 Macrophages exposed to acetylated LDL have a decreased rate of CSF-1R 
expression compared to non-exposed macrophages (Figure 3). Average values for total 
stained CSF-1R remains higher in the control cells up until 24 h post supplemental CSF-1 
removal. Looking only at surface CSF-1R, a clear trend is not apparent, however 
capturing surface CSF-1R can be fickle due to rapid internalization of receptor (Figure 4). 
After stimulation with CSF-1, the internalization and degradation CSF-1R appears to 
occur at the same rate in LDL exposed and non-LDL exposed macrophages (Figure 5). 
Phosphorylated CSF-1R was stained at lower concentrations in LDL exposed 
macrophages from when they came out of CSF-1 starvation media to the last time point 
recorded at half an hour after initial stimulation (Figure 6). 
Phosphorylation of ERK fluctuates but appears similar between LDL exposed cells and 
non-LDL exposed 
 The staining of pERK after CSF-1 ligand addition showed two significantly 
different time points at 7 min and 10 min, indicating a spike in the activation of non-LDL 
exposed macrophages at 7 min that rapidly decreases by 10 min (Figure 7). Previous 
experiment done with pERK showed no visible difference between the LDL exposed and 
non-LDL exposed macrophages.  
Phosphorylation of Akt remains similar between LDL exposed and non-exposed 
macrophages 3-60 min post CSF-1 but increases 10 h post CSF-1 exposure 
 The level and localization of phosphorylated Akt was investigated with a series of 
experiments. An initial CSF-1 stimulation time courses indicated that LDL treated 
macrophages had a higher level of nuclear phosphorylated Akt. However, this result was 
not duplicated in subsequent experiments. From repeated experiments it would appear 
that there is no difference in the level of cellular Akt (Figure 8). Though some individual 
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points are significantly different with Tukey’s test they do not hold up in replicates and 
do not seem to follow an obvious pattern. If the nuclear masks are used to make to graph 
the intensity of pAkt there is little difference observed from that quantification of the 
cellular masks. Looking past the timeline of initial experiments the phosphorylated level 
of cellular Akt is higher in non-LDL exposed macrophages from for the tested 10 h to 26 
h post CSF-1 stimulation (Figure 9). 
Proliferation is increased in LDL-exposed macrophages 24 h post LDL removal, but LDL 
exposure does not affect long term proliferation 
 Ki67 was stained in macrophages after they had been exposed to a 24 h pulse 
LDL. One-day post removal of LDL the LDL exposed cells saw a significantly higher 
expression of Ki67. After the initial spike in Ki67 expression, there does not appear to be 
a significant difference in the expression of Ki67. From this Ki67 staining experiment 
with a pulse of LDL it is apparent the lipid droplet filled morphology of the macrophages 
disappears almost entirely two days after the removal of the LDL from the cells (Figure 
10). 
Flow cytometry of LDL exposed macrophages 
 Surface staining and flow cytometry was done to characterize the macrophages. 
The lipid stain Nile red capture the change in lipid content with the use of flow 
cytometry. LDL exposed cells expressed higher of CD68. While non-LDL exposed cells 
expressed higher levels of CD11B and CD80. Expression of MHCII and CD14 appears to 
be similar (Figure 11). 
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The rate of CSF-1 stimulated macropinocytosis is similar in LDL-exposed and control 
cells 
 Live cells were imaged to investigate if being laden with lipid droplets had an 
effect on internalization of dye from the media via macropinocytosis. Initial experiments 
indicated a decrease in the ability of cells to take up dextran in a resting state; however, 
this result was not duplicated in subsequent experiments. Both treated and control cells 
were observed macropinocytosis dextran at the same rate and trafficking 
macropinocytosis dye from the media to lysosomes in a similar time frame (Figure 12). 
Discussion 
 CSF-1R signaling and degradation in lipid-laden macrophages is remarkably 
similar to non-LDL-exposed cells but CSF-1R expression and phosphorylation of CSF-
1R appear to be different. Even subtle changes in CSF-1R may shed light on what is 
happening in lipid-laden macrophages as CSF-1 activates chemotaxis, macropinocytosis, 
survival, and proliferation (Pixley and Stanley, 2004). The expression rate of CSF-1R is 
slowed in lipid-laden macrophages indicating that they may not be as responsive to CSF-
1 as non-exposed cells in a resting state. If the macrophages are deprived of the CSF-1 to 
upregulate CSF-1R and then stimulated with CSF-1, the receptor is degraded at the same 
rate. The degradation timeline for the receptor is significant as the receptor continues to 
phosphorylate Akt and ERK from the early endosome (Huynh et al., 2012). The same 
rate of receptor degradation between LDL-exposed and non-exposed macrophages 
indicates the time CSF-1R spends from CSF-1 binding to degradation is not altered by 
the presence of lipid droplets in the cell.  
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  Although the degradation of CSF-1R appears to be the same and the amount of 
the pCSF-1R level in LDL exposed cells is lower. This is true for phosphorylated CSF-
1R at Y723 throughout the observed 30 minutes after stimulation. There is not a clear 
explanation as to why there is a higher level of phosphorylated CSF-1R. CSF-1R 
expression in other experiments with the same experimental design appear to be similar 
indicating the increase in phosphorylated CSF-1R is not simply due to more CSF-1. 
 While the phosphorylation of CSF-1R after CSF-1 stimulation is depressed in 
LDL exposed cells the, phosphorylation of Akt at S473 is not different in the first hour 
but increases 10-26 h post CSF-1 exposure. The S473 phosphorylation of Akt is required 
for the maximum activation of the serine/threonine Kinase (Hart and Vogt, 2011). Ten 
hours past the initial signaling that occurs at CSF-1 addition, the level of cellular pAkt is 
increased in non-LDL exposed cells. The decreased level of pAkt in exposed cells could 
indicate that they are less prone to proliferation and more prone to apoptosis (Hart and 
Vogt, 2011).  
ERK is another significant signaling kinase how’s phosphorylation was at 
quantified at the Thr202/Tyr204 site. The spike in the phosphorylation of ERK in the 
non-LDL exposed cells at 7 min demonstrated that ERK’S phosphorylation is more 
sensitive to CSF-1 in these cells. Based solely on this result it would appear that lipid 
droplets suppress ERK phosphorylation which would lead to decreased cell proliferation.  
 Ki67 staining indicated a spike in macrophage proliferation after removal of LDL 
that quickly rejoined the non-LDL exposed cells. It does not appear that a 24 h pulse of 
LDL has an effect on the long term proliferation of the macrophages, but having lipid 
droplets increases proliferation with fresh CSF-1 addition. Ki67 is a protein found in cells 
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as they are actively growing but disappears when the cells enter a resting state (Scholzen 
and Gerdes, 2000). As Ki67 is only present in proliferating cells we can use it to 
determine what portion of the population is proliferating. Besides the Ki67 staining it is 
apparent from the lipid staining that the cells are able to clear the lipid droplets within 48 
h of LDL removal. From this experiment we are unable to tell if the disappearance of 
lipid laden macrophages is due to clearance of the lipid droplets from the macrophages or 
the death of the macrophages themselves. In future experiments it would be interesting to 
look at continuous LDL exposure throughout the course of the experiment rather than 
removing LDL from the culture medium at the start of the experiment.  
Looking at the expression of different surface markers can give us insight into the 
activation of our LDL exposed and non-exposed macrophages. Through the use of Nile 
Red the increased lipid content of the LDL-exposed cells is confirmed, as Nile Red is an 
effective lipid stain for use in flow cytometry (Greenspan et al., 1985). CD11b is a 
commonly used marker that is found on all cells of myeloid lineage (Murray and Wynn, 
2011). The integrin CD11b forms a heterodimer with CD18 forming complement 
receptor 3 (CR3, MAC-1) (Wagner et al., 2001). On macrophages active CD11b is 
associated with an inhibitory signal to T-cells, making it appear that the LDL-exposed 
cells are less inhibitory to T-cell than the non-exposed cells (Hume, 2008). CD68 is a 
scavenger receptor commonly used to identify macrophages as it is expressed by all 
macrophages. LDL exposed macrophages have higher expression of CD68 but lower 
expression of CD11b and CD80. CD80 is a costimulatory receptor needed for T-cell 
activation. The expression of MHCII and CD14 does not appear to be different between 
treated and non-treated macrophages.  
39 
 
Macropinocytosis is a cellular function stimulated by CSF-1 (Pixley and Stanley, 
2004). Macropinocytosis does not appear to differ between LDL-exposed and non-LDL 
exposed cells. This similarity appears to hold true for stimulated macropinocytosis, 
unstimulated macropinocytosis, and the traffic of macropinocytosis dye. It does not 
appear that being full of lipid droplets limits macropinocytosis in macrophages. This is in 
contrast phagocytosis where macrophages are limited in the number of particles that they 
can phagocytose due the limited membrane (Cannon and Swanson, 1992). It is possible 
that this difference occurs due in part to the lipid droplets being monolayer and the cell 
having time to synthesis more membrane. 
In conclusion, lipid-laden macrophages have some signaling differences that may 
lead to successful future treatments. Research in treatment strategies has begun to shift 
from only decreasing LDL and to keeping macrophages from entering and proliferating 
in plaques. By knowing which pathways are active in lipid laden macrophages and how 
these cells respond to growth factors we can make intelligent choices on how to target 
and influence them. 
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Chapter 3 
Conclusions 
The goal of this project was to apply our laboratory expertise in macrophage cell 
biology toward understanding CSF-1R signaling and trafficking in lipid-laden 
macrophages. This project was a new emphasis for the laboratory, and I established 
protocols for culturing lipid-laden macrophages and staining lipid droplets. Further, I 
developed pipelines in CellProfiler and wrote R code for statistics and graphing to 
quantify imaging data. 
I spent the bulk of my time developing methods to quantify immunofluorescent 
images of cell signaling, for example, phosphorylated Akt and phosphorylated ERK. 
These methods utilized four-color fluorescent images of which two colors were used to 
mask cells and nuclei, a third color was used to quantify a protein of interest and the 
fourth color was used to stain lipid droplets. In this approach both DAPI and phalloidin 
were used to create the cellular mask producing much more consistent masks and 
reproducible quantification of the fluorescence associated with the protein of interest 
across experimental conditions. Moving forward, it would be worth looking into the 
effects of focal plane on imaging results as the person imaging may shift planes slightly 
under different experimental conditions. 
The current experimental protocols have been successful, but going forward a few 
protocol changes would streamline the process and provide better protein quantification. 
Current protocols utilize macrophages grown on glass coverslips that are fixed, stained, 
and imaged manually. Though growing the macrophages on glass is a great approach for 
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high quality images, it is slow and labor intensive.  If only total or nuclear localization is 
of interest, then lower quality images would be sufficient. High content microscopy done 
in 96 well plates fills this niche, quickly providing a large number of mediocre images. 
Using 96 well plates with automated imaging has the advantage of: 
• faster more consistent image acquisition,
• removal of potential bias from person taking images, and
• lower volumes of antibodies and cells needed for each experiment and condition,
Utilizing 96-well plates with automated imaging compared to glass coverslips and 
manual imaging has the shortcomings of: 
• a steeper learning curve to set up experiments and optimize protocols,
• diminished picture quality with plastic and air lenses,
• “junk” in images that would not have been imaged by a user, and
• issues with uneven distribution of cells within the well (concentrated to the edges
of the well). 
If the lab decides that high content microscopy is going to be a major focus in 
future experiments, it may be beneficial to integrate robotic pipetting. The current high 
content microscopy system has a fluidics component that could be used to accurately 
reproduce time points, while at the same time keeping plates at a constant temperature 
and pH. A standalone pipetting robot with multiple pipette heads and wash capabilities 
could be beneficial, if a large volume of experiments were being conducted. Utilizing 
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such a robot would help to increase reproducibly and staining across all of the wells and 
with all users, while not using time on the high content microscope. 
By incorporating use of the imaging software, CellProfiler, into the laboratory, I 
have turned the qualitative assessment of signaling in immunofluorescent images into a 
quantitative analysis (Carpenter et al., 2006). CellProfiler provides a user-friendly 
interface that has the flexibility needed to capture the information of interest from a 
microscopy image. When analyzing images with CellProfiler, the user constructs a 
pipeline to extract data from the images. This pipeline does not modify the images 
themselves and shows all of the steps that were used to collect the data. The data 
exported from CellProfiler is in long format that is compatible with graphing and 
statistical analysis using the open source statistics package R. Through the combination 
of the CellProfiler pipeline and an R script anyone can see the steps used and reproduce 
the same analysis from the raw images. This is hugely powerful for reproducibility and 
transparency. 
Other methods besides the analysis of immunofluorescence images should be 
used to support and confirm findings. Flow cytometry could be used for markers such as 
Ki67 but would not be as effective for time sensitive protein phosphorylation as the cells 
must be detached from the plate. Western blots are the gold standard for quantifying 
proteins and post transcriptional changes, and any substantial claims from IF analysis will 
need to be backed by western blots (Mahmood and Yang, 2012). Western blots do require 
large numbers of cells and antibodies and would not be able to detect heterogeneous 
expression in the cell population. 
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 The main focus of my experiments was to observe the effect of CSF-1 on 
macrophages stimulation. Macrophages were removed from CSF-1 supplemented media 
so that the CSF-1R signaling and traffic would be synchronized within the cell to the 
addition of CSF-1. In looking at this synchronized signaling pAkt, pERK, and the 
degradation of CSF-1R appeared the same while the phosphorylation of CSF-1R was 
decreased in LDL exposed cells. The difference in CSF-1R phosphorylation is rather 
curious and begs the question as to why CSF-1 phosphorylation is decreased and what the 
signaling outcomes are downstream of this. 
 Looking farther downstream from the initial CSF-1 stimulation, phosphorylation 
in LDL-treated macrophages appear to be much different. The phosphorylation of Akt 
was the only signaling molecule investigated hours after an initial CSF-1 stimulation; but, 
it is significantly lower in LDL exposed cells. Other signaling molecules such as PI3K 
would be worth investigating as basal levels of phosphorylation in signaling cascades 
appear to be much different from the synchronized stimulated response.   
 Macrophages in this thesis were primarily loaded with acetylated LDL. 
Acetylated LDL does an excellent job of forming lipid-laden macrophages; however, it is 
not found in vivo and there is some dispute how its metabolism in the cell differs. 
Compared to acetylated LDL the oxidized components can impair LDL degradation and 
stimulate inflammatory phenotype (Wang et al., 2007). It may be worth transitioning to 
utilizing oxidized of even non-modified LDL for experiments to keep the experimental 
model as close to in vivo conditions as possible. It is also important to keep native LDL 
from becoming oxidized which would involve controlling exposure to oxygen. It may be 
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worth establishing a protocol for the isolation of LDL to cut cost and supply the lab for 
experiments that utilize high concentrations over long periods of time.  
 One interesting observation from the Ki67 experiments was the disappearance of 
lipid-laden macrophages two days after removal of the LDL containing media. It is not 
exactly clear whether these cell died or if they effluxed the cholesterol. It would be 
possible to determine what happened to these cells by observing the same field of view 
overtime. Regardless of what happened to the macrophages, the swift disappearance of 
the lipid-laden phenotype indicated that it may be important to keep the loaded 
macrophages exposed to LDL for the entirety of an experiment, especially if that 
experiment is hours or days long.  
The effect of lipid droplets on macrophage biology appears to offer many 
opportunities for discovery that the lab can investigate with the protocols I implemented 
and in directions that my experiments have indicated. CSF-1R signaling pathways appear 
similar when synchronized but appears to be different in LDL-exposed macrophages 
growth media. In the lab there are some exciting opportunities to further develop 
protocols for high content microscopy for investigating the timing and amplitude of 
different signaling events.  
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